One such medicine gaining strong attention in Peru is Advanced Molecules Semaglutide, a modern treatment used for Type 2 diabetes and weight management
Immunofluorescence staining
8 CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity, currently in Phase I, with the potential to be a best-in-class oral treatment for type 2 diabetes and chronic weight management
This attenuated body weight gain and significantly lower body weight may be driven by decreases in nutrient absorption with the loss of GLP-2R signaling 64
It is not approved for human or veterinary use and must not be used for consumption
A consultation with our medical team and comprehensive cognitive assessment are required to determine if this therapy is appropriate for you.